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a b s t r a c t
The Neural Crest, a transient epithelium in vertebrate embryos, is the source of putative stem cells
known to give rise to neuronal, glial and endocrine components of the peripheral (sensory, autonomic
and enteric) nervous system (PNS) and pigment cells in the skin. The Neural Crest is also widely believed
to be the source of mesectodermal derivatives (skeletogenic, odontogenic, connective tissue and smooth
muscle mesenchyme) in the vertebrate head [see (Bronner and LeDouarin, 2012; Le Douarin, 2012; Le
Douarin and Kalcheim, 1999); see also (Hörstadius, 1950; Weston, 1970)]. This conventional under-
standing of the broad developmental potential of the Neural Crest has been challenged over the past few
years (Breau et al., 2008; Lee et al., 2013a, 2013b; Weston et al., 2004), based on recognition that the
deﬁnition of the embryonic epithelia that comprise the Neural Crest may be imprecise. Indeed, the
deﬁnition of the embryonic tissues understood to constitute the Neural Crest has changed considerably
since it was ﬁrst described by Wilhelm His 150 years ago (His, 1868). Today, the operational deﬁnition of
the Neural Crest is inconsistent and functionally ambiguous. We believe that more precise deﬁnitions of
the embryonic tissues involved in Neural Crest development would be useful to understand (1) the range
of cellular phenotypes that actually segregate from it, (2) when this lineage diversiﬁcation occurs, and
(3) how diversiﬁcation is regulated.
In this idiosyncratic review, we aim to explain our concerns with the current deﬁnitions in this ﬁeld,
and in the chiastic words of Samuel Johnson (1781), “… make new things familiar and familiar things
new”.1 Then, we will try to distinguish the developmental events crucial to the regulation of Neural Crest
development at both cranial and trunk axial levels of vertebrate embryos, and address some of the
implicit assumptions that underlie the conventional interpretation of experimental results on the origin
and fates of Neural Crest-derived cells. We hope our discussion will resolve some ambiguities regarding
both the range of derivatives in the Neural Crest lineage and the conventional understanding that cranial
mesectodermal derivatives share a common Neural Crest-derived lineage precursor with components of
the PNS.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
"Theories have four stages of acceptance: i) This is worthless
nonsense; ii) This is an interesting, but perverse, point of
view, iii) This is true, but quite unimportant; and iv) I always
said so.” [from a book review by J.B.S. Haldane (Haldane,
1963)]."
Historic Background
His (His, 1868) ﬁrst recognized and described a distinct band of
cells that lay between the dorsal neural tube and the epidermal
epithelium at the neurula stage of avian embryo development. He
operationally named this transient structure Zwischenstrang and
suggested, from morphological studies, that its cells were the
source of peripheral ganglia. Subsequently, Marshall (Marshall,
1879) named this domain of cells the Neural Crest. He described
the Neural Crest as the “outgrowth” of cells formed by the fusion
of the longitudinal “neural ridges” after they meet in the embryo-
nic midline to form the neural tube (which he referred to as the
“neural canal”) and after the overlying epidermal epithelium (which
he called the “external epiblast”) separates from the neural tube.
Importantly, Marshall explicitly distinguished the Neural Crest,
which appears to be part of the dorsal epithelium of the nascent
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neural tube, from its antecedent, the paired neural ridges, what we
now call the dorsal ridges of the embryonic neural folds. He
described these ridges as the “reentering angle between the
external epiblast and the neural canal”—clearly indicating that
the folds included both epidermal and medullary (neural) epithe-
lia. As we will discuss further in the Formation of the Neural Crest
section, the Neural Crest might more accurately be considered a
portion of the dorsal neural tube epithelium that forms after the
paired neural folds fuse in the embryonic midline to create the
neural tube and after the neural epithelium separates from the
overlying epidermal epithelium.
Julia Platt is often credited as the ﬁrst to suggest, 120 years ago,
that the Neural Crest was the source of skeletal and connective
tissue derivatives in the head of amphibian embryos (Hall, 1999).
Platt's detailed histological descriptions (Platt, 1891a, b; Platt,
1893, 1894) led her and a few others to infer that cells forming
the cranial skeleton originated from a lateral epithelial domain of
the embryonic neural folds. Her main point—that skeletogenic
mesenchyme (“Mesectoderm”) arose from ectodermal epithelium
—caused a serious controversy in the ﬁeld of comparative mor-
phology. This controversy, nicely summarized by Landacre
(Landacre, 1921), arose because it contradicted a major tenet of
the Germ Layer Theory, which had stipulated that mesoderm was
the embryonic germ layer that produced skeletal and connective
tissues, as well as muscle, blood and vascular tissues. Although
Platt's audacious challenge to the classical Germ Layer Theory was
manifestly deleterious to her scientiﬁc career, it is important to
emphasize that she was not responsible for making the Neural
Crest “famous” as the source of skeletogenic mesenchyme [see
(Hall, 1999)]. Rather, she seems to have claimed only that the
ectoderm of the neural folds, including the dorsolateral and
epibranchial epithelium, produces mesectodermal connective tis-
sue as well as peripheral ganglia.2 The assertion that the Neural
Crest was the source of skeletogenic mesenchyme should, instead,
more appropriately be attributed to the numerous pioneers in the
newly emerging ﬁeld of experimental embryology who undertook
to establish the developmental fates of embryonic cells and map
them to epithelial locations in developing embryos.
Fate-mapping
Various experimental approaches have been used to test the
normal developmental fates of cells in early embryonic epithelial
domains. The details and limitations of the classical cell marking
and fate-mapping studies have been critically reviewed elsewhere
(Le Douarin and Kalcheim, 1999; Weston, 1970), but they all
primarily used amphibian and avian embryos and employed one
or more of the following three basic experimental procedures:
(1) surgically ablating speciﬁc embryonic regions followed by an
assessment of the resulting structural lesions; (2) marking speciﬁc
locations of embryonic epithelia with vital dyes or other extrinsi-
cally applied substances followed by analysis of the fates of
marked cells; and (3) observing the fates of cells derived from
transplanted tissues of embryonic donors whose cells had been
labeled with intrinsic or applied markers. The validity of the
inferences from all these procedures depends on the speciﬁcity
of the marking method. Such speciﬁcity, in turn, depends on
knowing accurately what tissues were ablated or transplanted,
assuring that extrinsic markers were precisely applied to known
embryonic locations and not transferred to adjacent cells, and
ﬁnally, assuring that intrinsic markers were not expressed in
tissues or regions other than the one designated. As we shall
discuss below, problems of interpretation arise when these criteria
are not fulﬁlled.
The experimental embryologists conﬁrmed the various deriva-
tives of putative Neural Crest, and their studies—including the
controversial suggestion that Neural Crest derivatives included
cranial (visceral arch) structures, odontoblasts, and osteoblasts of
dermal bone—were considered in an inﬂuential descriptive paper
by de Beer (de Beer, 1947), who pronounced that such studies
showed “unequivocally” that Neural Crest was the source of
skeletogenic mesenchyme. He went on to name these putative
crest-derived precursors “Ectomesenchyme”.3 These early experi-
mental analyses of Neural Crest development culminated in
Hörstadius' inﬂuential review (Hörstadius, 1950), who summar-
ized the work of his student Sellman and other workers who had
mapped the developmental history and fates of the cells thought
to originate from the Neural Crest of amphibian embryos.
It is important to recognize, however, that the original marked
domains in all of the relevant fate-mapping studies included not
only the Neural Crest itself, as described by Marshall (Marshall,
1879), but also the adjacent, lateral non-neural epithelia of the
neural folds (see Fig. 1). In his review (Hörstadius, 1950), Hörsta-
dius explicitly acknowledged the ambiguity of whether the Neural
Crest was an outgrowth from the spinal cord or a separate
rudiment, and noted discrepancies in the comparative morphol-
ogy literature about the “position of the crest material in relation
to the thick neural plate and the thinner presumptive epidermis.”
These discrepancies are illustrated in Fig. 2. Signiﬁcantly, Hörsta-
dius followed Raven's (Raven, 1931) speciﬁc conclusion that the
entire ectoderm of the dorsal neural fold (see Fig. 2A) consists of
presumptive Neural Crest cells, and explicitly dismissed potential
problems of interpretation by asserting that
“…these discrepancies are of minor importance for the experi-
mental worker, as in any case crest cells in Urodeles at the
stages used for operation are situated in the ridges that are
extirpated or transplanted.”
This conclusion affected the interpretation of experiments in
this ﬁeld for the next half-century. Thus, in the years that followed
Hörstadius' review, the operational deﬁnition of Neural Crest was
implicitly changed to include not only the dorsal ridges of the
neural epithelium but also the lateral non-neural epithelium of the
embryonic neural folds. Subsequent “neo-classical” grafting stu-
dies (Johnston, 1966; Noden, 1975; Weston, 1963) largely con-
ﬁrmed the various derivatives that had previously been attributed
to the trunk and cranial Neural Crest, and began to map more
precisely the timing and pathways of the migration of Neural
Crest-derived cellular precursors of these derivatives, using
tritiated-thymidine as a precise and relatively durable marker of
donor cell nuclei. Conforming with these earlier mapping studies
in amphibian embryos, pharyngeal cartilages and dermal bone
were seen to be populated by graft-derived cells at rostral axial
levels but, where neural fold grafts at all axial levels gave rise to
connective tissue derivatives, grafted tissues from trunk axial
levels of amniote embryos failed to contribute cells to skeletogenic
mesenchyme in the trunk.
2 Platt's actual, rather convoluted, summary statement (1894) was: “Die aus der
Neuralleiste und aus der dorsolateralen und epibranchialen Verdickungen des
Ektoderms ausgehenden Zellen bilden nicht allein Nerven, denn eine jede dieser
Anlagen trägt sowohl zur Bildung des mesektodermalen “Bindegewebes” wie zur
Bildung der Ganglien bei, und nachdem Ganglien und “Bindegewebe” sich von
einander getrennt haben schliessen sich Ektodermzellen noch weiter den beiden
Abtheilungen des Mesektoderms an.”
3 Strictly speaking, the name “Ectomesenchyme” should include any population
of mesenchymal cells, regardless of their subsequent developmental fate, that
delaminate from ectodermal epithelium. To distinguish mesoderm-like, skeleto-
genic mesenchyme from mesenchyme that originates from “authentic” Neural
Crest, therefore, it would probably be better to refer to the former as “Mesecto-
derm” (Le Douarin et al., 2004; Le Douarin and Kalcheim, 1999).
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Fig. 1. Classic marking, grafting and ablation studies involved both neural and non-neural epithelia of the embryonic neural folds. This ﬁgure, taken from Hörstadius'
inﬂuential monograph, documents the fact that the classical fate-mapping studies did not distinguish derivatives originating from lateral non-neural epithelium of the neural
folds and the Neural Crest, as originally deﬁned (Marshall, 1879). (A) Neural ridge staining with neutral red (coarse stippling) and Nile blue (ﬁne stippling). (B) Open neural-
plate stage with staining marks as in (A). The head neural ridge is divided into 8 zones. (C) Left side is the epidermal line of coalescence (broken line), line of coalescence of
the brain (dotted line), and presumptive ectomesenchyme (hatched region). Right side marks zones 1–8, showing the position of presumptive anterior trabeculae (a.Trab),
mandibular arch (Mand.a), hyoid arch (Hy.a.), and gill arches. Full lines, vital staining; broken lines, extirpation and transplantation experiments. (D) Stained
ectomesenchyme migrating under the epidermis along the endomesodermal mandibular, hyoid, 1, 2, and 3þ4 gill arches.
Source: Reproduced from S. Hörstadius (1950, p. 41).
Fig. 2. Participation of non-neural epithelium and the adjacent neural epithelium of the medullary (neural) plate of the neural fold has been ambiguous since the Neural
Crest was ﬁrst described in the classical descriptive embryology literature. This ﬁgure, taken from Hörstadius' historic monograph, illustrates the uncertainty about which
ectodermal epithelial components were actually thought to comprise the putative Neural Crest. Eventually, the author declared (pp. 4–5) that the distinction was
operationally irrelevant, since both tissues were involved in the experimental mapping procedures. Figure shows the position of Neural Crest material (dotted) of
Ambystoma during neurulation using transverse sections. (A1–A4) according to Raven, Roux Arch. 1931:125; (B) according to Feutrez, Bull. Acad. Belique 1942; (C) according
to Baker and Graves J. Comp. Neurol. 1939:71.
Source: Reproduced from S. Hörstadius (1950, p. 5).
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Around the same time, Le Douarin and her colleagues intro-
duced the use of a quail-speciﬁc nucleolar marker as a permanent
way to distinguish donor-derived cells from host cells and tissues
(Le Douarin, 1973, 1969; Le Douarin and Barq, 1969), and con-
ﬁrmed inferences about cell migration pathways and cell types
attributed to trunk and cranial Neural Crest-derived cells. Their
work, further validated by Noden's detailed inferences (Noden,
1975), revealed that labeled grafts from rostral axial levels of avian
embryos were able to produce skeletogenic mesenchyme, whereas
labeled grafts from more caudal axial levels of the embryo did not
do so. They went on to conclude that trunk Neural Crest-derived
cells in amniote embryos had lost the skeletogenic ability that was
present in anamniotes (Baker et al., 1997; Bronner and LeDouarin,
2012; Le Douarin, 2012; Le Lievre, 1978; Le Lievre and Le Douarin,
1975), but this conclusion—as the reader is likely becoming aware
—was based on the previous assumption that the tissues grafted at
trunk axial levels were comparable to the tissues grafted at cranial
levels.
It later became clear that, indeed, grafted tissues at trunk and
cranial axial levels were not comparable: neural tube segments
lacking non-neural epithelium had been transplanted in the trunk,
whereas neural folds containing both neural and non-neural
epithelium were transplanted at more rostral axial levels. And it
was through the thorough critical analysis of these published
diagrams (Fig. 3) that it became apparent that the transition from
grafts with skeletogenic ability to those without exactly corre-
sponded to the levels where neural fold grafts in developmentally
younger embryos could be operationally replaced by grafts of
neural tube segments from which the non-neural epidermal
epithelium had already separated from the dorsal neural tube
epithelium. Based on this insight, Weston et al. (Weston et al.,
2004) suggested more parsimonious inferences: (1) that tissues
grafted at the two axial levels were not equivalent; and (2) that the
skeletogenic ability of graft-derived cells correlated with the initial
presence of non-neural epithelium-containing neural fold grafts
and, conversely, the lack of skeletogenic ability by graft-derived
cells resulted from the absence of such a non-neural epithelial
component in the grafts of neural tubes.
The deﬁnition of “Neural Crest” has changed over time
As ﬁrst noted by Hill in 1920 [and published much later; (Hill
and Watson, 1958)], the idiomatic use of the name “Neural Crest”
changed so that it included not only the epithelial domains in the
dorsal neural folds but also the cells that “proliferate” from them.
This proliferation is what we now know to be the developmentally
regulated events of Epithelial–Mesenchymal Transition (EMT), a
general, morphogenetic process that occurs at various times
during development and in many embryonic tissues (see the
EMT and the onset of cell migration section). Although EMT is
deﬁnitely not unique to the Neural Crest epithelium, the molecular
attributes of this process, such as Snail1 or Snail2 expression
(Aybar et al., 2003), have become the deﬁning, yet perhaps
misleading (see the Neural crest epithelium and lateral non-
neural epithelium of neural folds are phenotypically distinct
section), markers for “Neural Crest”. Thus, the term “Neural Crest”
came to be used to indicate both the epithelium of the neural fold
and the mesenchymal cells that dispersed along deﬁned migration
pathways in the embryo after they emerged from this epithelium.
Consequently, it became an ever more imprecise way to refer to
migrating mesenchymal cells and their derivatives as well as the
epithelium from which this mesenchyme derived. Such usage
further obfuscated the neural lineages of cells derived from what
we will later introduce as “Authentic” Neural Crest epithelium (see
the Formation of the Neural Crest section) and, at the same time,
implicitly ceded greater developmental potential to it. By ignoring
the possible heterogeneity of the neural fold epithelium and
deﬁning the entire region as “Neural Crest”, we and most other
workers in the ﬁeld eventually concluded that Neural Crest-
derived cells possessed remarkably broad developmental potential
Fig. 3. Details of grafting protocols reveal that donor-derived mesectodermal derivatives were present in host embryos when neural fold epithelium was transplanted, but
were absent in host embryos when the graft lacked lateral non-neural epithelium. Operationally, orthotopic grafts of cephalic neural folds were performed in early embryos,
before the neural folds had joined in the midline to form the neural tube. Conversely, orthotopic grafts of neural tube segments were performed at more posterior axial levels
in older host embryos, after the neural tube segments from donor embryos had separated from overlying epidermis.
Source: Reproduced from Le Lievre and Le Douarin (1975) with permission from Development, The Company of Biologists.
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(Le Douarin and Kalcheim, 1999; Weston, 1970, 1991), including
pigment, neural, glial and endocrine cells, and various skeletogenic
and connective tissue derivatives (ﬁbroblasts, as well as smooth
muscle, angiogenic, odontogenic, and corneal stromal cells). In the
following sections, we describe more precisely how the Neural
Crest domain is induced and the topology and the dynamic events
occurring during neurulation in the junctional area between the
non-neural and neural epithelium. It is through this process that
we are prompted to redeﬁne what actually constitutes the Neural
Crest.
Formation of the Neural Crest
Induction of Neural Plate Border (NPB) epithelium
Following neural induction (reviewed by Groves and LaBonne,
2014; Harland, 1994), the embryonic ectoderm consists of two
morphologically distinct epithelial domains: the thickened neural
epithelium (the neural or medullary plate) and a thinner, non-
neural epithelium. More recent works suggest that planar signal-
ing—possibly involving Bone Morphogenetic Protein [BMP; (Aybar
et al., 2003)]—establishes the Neural Crest potential within cells
that reside at the boundary of the two epithelia (neural plate
border, NPB) (Aybar and Mayor, 2002; Dickinson et al., 1995;
Moury and Jacobson, 1989; Selleck and Bronner-Fraser, 1995;
Trainor, 2005; Simões-Costa and Bronner, 2015). Thus, when
medullary epithelium is transplanted ectopically into areas of
non-neural ectoderm, diagnostic markers of Neural Crest (neuro-
nal and pigment cells) appear within the host epithelial tissue. It is
noteworthy, however, that no cells characteristic of skeletogenic
mesectoderm are recognized in the responding epithelium. This
apparent discrepancy might suggest that the induction of ecto-
dermal epithelial cells to acquire Neural Crest developmental
potential is different from those developmental events that lead
cells to acquire skeletogenic potential.
More recently, other molecular components of signaling path-
ways said to be involved in Neural Crest induction have been
identiﬁed (Hong and Saint-Jeannet, 2007; Jones and Trainor, 2005;
Monsoro-Burq et al., 2003). In Xenopus, for example, FGF8 and
Wnt 8 have been reported to play roles in this signaling (Hong
et al., 2008). But, again, it should be noted that the molecular
markers used as assays to identify “Neural Crest”—such as Snail2
and Sox9—are, in fact, co-expressed in cells at the NPB and in
neural folds that will undergo EMT. These issues, as well as the
inductive mechanisms leading to skeletogenic mesenchyme in the
head, will be explored next.
Morphogenetic events leading to segregation of NC epithelium
At the onset of neurulation, the edges of the neural plate begin
to elevate in a rostral-to-caudal sequence to form the neural folds.
As initially described by His (see above), the dorsal-most portions
of the neural folds—the paired dorsal ridges—converge and fuse at
the embryonic midline to form a closed neural tube. As part of this
morphogenetic event, the lateral portion of the neural fold
epithelium delaminates to form a separate epidermal epithelium
overlying the neural tube (Duband and Thiery, 1982; Martins-
Green, 1988; Tosney, 1982).4 After neural tube closure, a Neural
Crest domain appears within the epithelium of the dorsal neural
tube, and from this epithelial domain, Neural Crest-derived
mesenchymal cells subsequently emerge as a result of the regu-
lated events of EMT (see the EMT and the onset of cell migration
section).
Although the morphogenetic events leading to neural tube
formation are similar at all axial levels, the details of neural tube
closure and the emergence of mesenchymal cells from the neural
fold epithelia at rostral axial levels differ from what occurs in the
trunk. Speciﬁcally, at rostral axial levels (generally considered to
start at the hindbrain, roughly anterior to the ﬁfth pair of somites),
putative Neural Crest cells are thought to undergo EMT before the
dorsal ridges of the neural fold fuse in the midline, therefore
resulting in the emergence of mesenchymal cells from neural fold
epithelium before the neural tube is formed. To complicate
matters, the acute folding at the dorsal ridges during convergence
of the rostral neural folds eventually causes the non-neural
component of the structurally heterogeneous neural fold epithe-
lium to be superimposed onto the neural epithelium. In early
morphological descriptions (see, for example, Fig. 2), these super-
imposed layers were difﬁcult to distinguish so the actual source of
mesenchymal cells that emerged from these epithelia could not be
ascertained.
Eventually, however, E-cadherin immunoreactivity provided an
opportunity to distinguish the non-neural and neural epithelia of
the neural fold, even when they were superimposed on each other
prior to the fusion of the dorsal ridges (see Figs. 4 and 5).
Cadherins provide a speciﬁc adhesion mechanism that can med-
iate cell recognition and tissue segregation during morphogenesis
(Edelman et al., 1983; Gumbiner, 2005; Takeichi, 1991), and the
properties and role of cadherin-mediated cell adhesion mechan-
isms have been thoroughly reviewed in the recent literature
(McKeown et al., 2013; Taneyhill and Schiffmacher, 2013).
E-cadherin is initially expressed in both the lateral non-neural
epithelium and in the neural plate, and is particularly concen-
trated at adherens junctions. At some time during neural fold
elevation, however, E-cadherin is progressively down-regulated in
the neural epithelium and replaced by N-cadherin, while the non-
neural domain of the neural fold continues to express high levels
of E-cadherin at the epithelial cell surfaces. Thus, as the paired
dorsal ridges meet in the midline, cadherins characteristic of the
two distinct epithelial domains presumably mediate not only
fusion of the folds but also delamination of the two epithelia to
form the dorsal neural tube epithelium separate from the over-
lying epidermal epithelium (Edelman et al., 1983; Gumbiner, 2005;
Takeichi, 2011).
Adhesion mechanisms within the dorsal neuroepithelium are
subsequently modiﬁed so that cells with Neural Crest potential
down-regulate N-cadherin function and establish adhesions
mediated by type 2 cadherins. Some of these type 2 cadherins
(cadherin-6, cadherin-7 and cadherin-11) are expressed by Neural
Crest-derived cells and are associated with the segregation of a
distinct, coherent domain of Neural Crest epithelium from the
neural epithelium (Dady et al., 2012; Duband, 2006; Nakagawa
and Takeichi, 1998; Taneyhill and Schiffmacher, 2013). This has
been noted in both chick and mouse embryos at trunk and cranial
axial levels. In Xenopus, however, a switch from E- to N-cadherin
operates at cranial levels only. Recent studies suggest that N-
cadherin plays a major role in collective cell migration in coopera-
tion with a chemotactic mechanism (Barriga et al., 2013;
Theveneau et al., 2010, 2013). It is likely that, in all instances, cells
that have dissociated from the Neural Crest epithelium exhibit
weaker intercellular adhesion than when they resided within the
neural epithelium, which subsequently facilitates their migration—
individually and collectively—following EMT (Nakagawa and
Takeichi, 1998; Theveneau and Mayor, 2012; Thiery et al., 2012).
As previously intimated, we will hereafter refer to this nascent
epithelial domain in the dorsal neural tube as “Authentic Neural
4 In teleost embryos, the morphogenetic events leading to neural tube formation
are slightly different, but still involve dorsal convergence of lateral non-neural
epithelium toward the embryonic midline, and eventual partitioning of neural from
epidermal epithelia.
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Crest”. Authentic Neural Crest epithelium exists only transiently
within the dorsal neural tube. As Neural Crest-derived cells
emerge from this epithelium, basal laminae assemble and “punc-
tuate” their structural separation from the polarized neural and
epidermal epithelia [(Erickson and Weston, 1983; Tosney, 1978);
for additional details, see Erickson and Perris (1993)]. The forma-
tion of such basal laminae by the respective epithelia operationally
enables embryos to be micro-dissected so that the distinct domain
of Neural Crest-epithelium can be distinguished from neural and
epidermal epithelia by scanning electron microscopy (Fig. 6).
Consistent with the inferred mechanisms to segregate authen-
tic Neural Crest from neural tube epithelium, antibodies that block
the function of the neural cell adhesion molecule (N-CAM) and
N-cadherin have been reported to cause Neural Crest cells to
detach from the neural epithelium and to self-associate as clusters,
but not to initiate Neural Crest cell migration [(Bronner-Fraser
et al., 1992); see also the seminal review by Erickson and Perris
(1993)]. Likewise, when Neural Crest-derived cells that express
type 2 cadherins are prevented from migrating by blocking the
interaction between integrin subunits and ﬁbronectin (FN), the
cells form cohesive clusters and appear to re-express N-cadherin
(Boucaut et al., 1984; Monier-Gavelle and Duband, 1997). Indeed,
in vitro studies using the S180 sarcoma cells have shown that
signaling by trunk crest cell migration pathways is promoted
when cells express cadherin-7 but abrogated when they express
N-cadherin. Similarly, S180 cell aggregates spread as a cohesive
sheet when expressing N- or E-cadherin but transform into
mesenchymal-like migratory cells when expressing cadherin-7 in
response to FN substrata. Force measurement assays further
support these ﬁndings, showing that the strength of adhesion
generated by cadherin-7 interactions cannot compete with FN–
integrin-generated forces. However, FN–integrin interactions can
be overcome by N-cadherin-mediated adhesive strength (Chu
et al., 2006; Dufour et al., 1999; Martinez-Rico et al., 2010).
Parenthetically, this kind of selective adhesion among newly
segregated Neural Crest cells resembles the clustering of Neural
Crest-derived cells from explanted segments of avian neural tubes
on culture substrates that do not support attachment or cell
dispersal (Glimelius and Weston, 1981; Loring et al., 1981). The
molecular basis for this cohesive behavior was not considered at
the time but, in retrospect, it is tempting to suggest that new
adhesive mechanisms involving type 2 cadherins help establish
Neural Crest cell-speciﬁc adhesive afﬁnities that are distinct from
their previous neuroepithelial adhesions. This idea remains to be
tested but, as discussed in the Fate-restriction and lineage diversi-
ﬁcation in Neural Crest-derived and Metablast-derived cell popu-
lations section, these enriched populations of Neural Crest-derived
cells do provide useful opportunities to identify the presence of
Fig. 4. E-cadherin immunoreactivity distinguishes neural and non-neural epithelia in the cephalic neural folds. Whole-mount showing PDGFRα-immunoreactivity in somites
and cranial and caudal neural folds of an e8.5 mouse embryo. (a)–(c) The planes of section, located as indicated in the whole-mount photograph, reveal a sharp boundary
between the neural epithelium of the neural plate and E-cadherin-positive non-neural epithelium, which is tightly associated with the neural epithelium in the dorsal ridges
of the neural fold. (b0 , bʺ) Details of the portion of the dorsal ridge indicated by the box in (b). (b0) In addition to cells with bright, cell-surface E-cadherin
immunoﬂuorescence, the region indicated by the arrowhead contains cells that have down-regulated E-cadherin (see Breau et al., 2008) and exhibit reduced cytoplasmic
staining. (bʺ) PDGFRα-immunoreactivity is co-expressed by the E-cadherin-positive epithelium of the dorsal ridges (yellow) and in cells with reduced cytoplasmic
E-cadherin-IR (orange). The apparently broad distribution of PDGFRα-immunoreactive cells in these preparations might be misleading, since the tyramide ampliﬁcation used
to enhance PDGFRα-immunostaining causes signiﬁcant, non-speciﬁc background ﬂuorescence.
Source: Adapted from Weston et al. (2004) with permission from John Wiley & Sons. Copyright© 2003 Wiley-Liss, Inc.
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Fig. 5. Cranial neural folds contain distinct domains of neural and non-neural epithelia. At early stages of neurulation, cells undergoing EMT display Snail2-
immunoreactivity, which is initially present primarily in the E-cadherin-positive non-neural domains (see, for example, the composite photos in Panel B, d and h, and
Panel C, d and h). Parts a–d show an overview, whereas parts e–h show a higher magniﬁcation of the neural fold. Panel A shows Sox1 staining. Scale bars, 20 mm.
http://dx.doi.org/10.1242/dev.094680.
Source: Reproduced from Lee et al. 2013b with permission from Development, The Company of Biologists.
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developmentally distinct subpopulations that are initially present
in the clusters and, ultimately, to understand how environmental
factors affect their subsequent fate (Maynard et al., 2000; Vogel
and Weston, 1988).
In any case, the partitioning of Neural Crest identity within the
dorsal neural tube epithelium and the emergence of authentic
Neural Crest-derived cells from this epithelium (discussed further
in the following section) appear to be independently regulated
developmental events. Whatever the mechanisms, these events
occur after the non-neural epithelium of the neural fold separates
to form the distinct epidermal epithelium overlying the neural
tube, and do not involve the lateral non-neural epithelium of the
neural fold.
EMT and the onset of cell migration
Genetic Regulation of EMT
EMT—the process by which cells dissociate from an epithelium
—is a precisely, yet complexly, regulated event that occurs in many
epithelia during embryogenesis, wound healing and in cancer
metastasis (Ahlstrom and Erickson, 2009; Lim and Thiery, 2012;
Thiery et al., 2009). EMT in the Neural Crest epithelium (Duband
et al., 1995) coincides with, and is presumably controlled by, the
expression of a number of regulatory genes in epithelial cells.
These genes include members of the Snail family, which are
thought to control the down-regulation of cadherins (Aybar
et al., 2003; Nieto et al., 1994). In turn, the expression of the Snail
family genes is responsive to a regulatory pathway that includes
Zeb-2, NF-κB, and Twist-1 (De Craene and Berx, 2013; Lim and
Thiery, 2012; Nieto, 2002; Peinado et al., 2007; Thiery et al., 2009;
Zhang and Klymkowsky, 2009), and some of these genes are
suppressed by the Grainyhead-like (GRHL2) gene product [see
Fig. 7; (Cieply et al., 2013, 2012)]. Because they are also expressed
in the lateral neural fold epithelium and, subsequently, in
mesenchymal cells that dissociate from the neural fold as well as
Neural Crest epithelium, these two epithelial domains have been
conﬂated, and many of these genes have been called “Neural Crest
speciﬁers” (Meulemans and Bronner-Fraser, 2004; Sauka-Spengler
and Bronner-Fraser, 2008). It is important to note, however, that
these genes are also expressed in different combinations during
other EMT events in embryos, including the formation of meso-
derm during gastrulation and during the emergence of sclerotome
mesenchyme from epithelial somites; thus, the usefulness of
denoting these genetic markers as unique indicators of Neural
Crest identity is not clear.
Fig. 6. Stages of partitioning of Neural Crest-derived cells from the dorsal neural tube epithelium can be visualized in SEM preparations. In this example, progressive stages
of Neural Crest cell segregation from the neural tube epithelium can be seen at caudal to rostral axial levels of a 20-somite (19 h) zebraﬁsh embryo. (A) SEM montage shows
the dorsal view (rostral to the left). (B) The outlines of Neural Crest cells and somites have been redrawn, with areas in (C)–(E) indicated in the boxes. Caudally (E), the Neural
Crest has not yet segregated from the dorsal neural epithelium of the neural tube. Rostrally (C), Neural Crest cells have begun to disperse after epithelial to mesenchymal
transition (EMT) into adjacent cell-free interstitial spaces (the Migration Staging Area or MSA). Between these extremes (D), Neural Crest epithelium has partitioned from the
dorsal epithelium of the neural tube, but has not yet undergone EMT prior to the onset of cell dispersal. Scale bars, (A, B) 125 mm; (C)–(E), 62 mm.
Source: Reproduced from Raible et al. (1992) with permission from John Wiley & Sons. Copyright© 1992 Wiley-Liss, Inc.
Fig. 7. Regulation of EMT involves multiple molecular components on several
interacting pathways. In this suggested scheme the Grainyhead-like gene 2 and
ZEB1 reciprocally inhibit each other. Such a regulatory loop allows ﬁne tuning of
EMT. GRHL2 function is also controlled by other genes expressed in epithelial cells
that undergo EMT.
Source: Adapted from Cieply et al. (2012, 2013).
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Regulation of cell migration in embryonic interstitial spaces
Tissue plasminogen activator (PA) (Erickson and Isseroff, 1989) and
matrix metalloproteases [MMPs; for example, members of the ADAMs
family (Alfandari et al., 1997; Duong and Erickson, 2004; Hall and
Erickson, 2003)] are also expressed in Neural Crest-derived cells, and
are thought to modulate cell attachment and locomotion in matrix-
ﬁlled interstitial spaces, and thereby function as inhibitors or promo-
ters of EMT and cell locomotion. PA is produced by most cells that
invade extracellular matrix (ECM)-ﬁlled interstitial spaces, and is part
of an elaborate system regulating localized proteolysis associated with
the cells' invasive properties (Menoud et al., 1989; Theuring et al.,
1995; Valinsky and Le Douarin, 1985). A promoter of human tissue PA
(Ht-PA) has been exploited to drive Cre-recombinase in transgenic
mice and, thereby to mark putative migrating Neural Crest-derived
cells (Pietri et al., 2003). However, since MMPs are expressed by
somitic mesoderm cells as well as by mesenchymal cells in the
branchial arches (see Fig. 8), neither they nor PA unequivocally
indicates that such cells originate from Neural Crest epithelium. Like
molecular markers of EMT, they are, in fact, attributes of cells under-
going morphogenetic events, regardless of their embryonic tissue of
origin. Unfortunately, the fact that such in situ expression patterns
have been widely adopted as early markers of Neural Crest-derived
cells has made it difﬁcult to consider the possibility that some lineages
originated in a developmentally distinct epithelial domain within the
neural folds [see below; and Weston et al. (2004)].
As indicated earlier, cells that have undergone EMT from the
dorsal epithelium of the trunk neural tube subsequently enter the
adjacent, matrix-ﬁlled interstitial spaces that we have called
the Migration Staging Areas [MSAs; (Weston, 1991); Fig. 9]. In the
trunk, the MSA is delimited by the basal laminae of the epidermal
epithelium, the neural tube, and the epithelial somites. A similar,
larger matrix-ﬁlled interstitial space also exists as a potential MSA
at cranial axial levels (Wehrle-Haller and Weston, 1997) but this
space lacks the epithelial component and associated basal lamina
provided in the trunk by mesodermally derived somites. Initially,
at both cranial and trunk axial levels, these interstitial spaces
contain large, hydrated ECM glycosaminoglycans (GAGs), such as
hyaluronan, and various proteoglycan macromolecules (Pratt et al.,
1975; Toole and Underhill, 1983; Weston, 1983; Yamada, 1983a).
It also contains basal lamina-associated proteins, such as laminin
and FN (Perris and Perissinotto, 2000). Eventually, in avian and
mammalian embryos, sclerotome cells formed by EMT from the
epithelial somites also deposit FN in the ECM of the trunk MSA.
This matrix component then provides a substratum known to be
used by Neural Crest-derived cells for locomotion (Newgreen and
Thiery, 1980; Newgreen et al., 1982; Rovasio et al., 1983; Yamada,
1983b). Direct observations of Neural Crest-derived cells in zebra-
ﬁsh embryos suggest that similar—but not identical—changes in
somite structure precede Neural Crest cell dispersal on interstitial
migration pathways (Eisen and Weston, 1993; Raible et al., 1992).
Cells undergo precocious EMT from lateral non-neural epithelium of
the Cranial Neural Folds
As previously mentioned, putative cranial Neural Crest-derived
cells in amniote (e.g., mammalian and avian) embryos are gen-
erally thought to emerge sooner than trunk Neural Crest-derived
cells—before the approximation and fusion of the dorsal ridges of
the cranial neural folds in the midline to form brain “neuromeres”
and before the subsequent segregation of Neural Crest epithelium
from the dorsal neuroepithelium of the nascent neural tube. This
inference, however, was based on the “classical” operational
deﬁnition of Neural Crest, which included both the dorsal ridges
and the lateral non-neural epithelium of the neural fold. It is
important to recognize that, unlike in the trunk MSA, there is no
somite epithelium at rostral axial levels to help establish favorable
conditions for the migration of crest-derived cells into such an
interstitial space. Consequently, before newly emerged Neural
Crest-derived mesenchyme enters the cranial MSA, this large
interstitial space lacks the mesodermally derived ﬁbroblasts that
are considered to be the source of interstitial FN in the trunk ECM.
Instead, before Neural Crest-derived cells enter the cranial MSA,
the function of such ﬁbroblastic cells appears to be subsumed by
the subpopulation of cells resembling sclerotome ﬁbroblasts that,
as we will discuss in the Neural Crest epithelium and lateral non-
neural epithelium of neural folds are phenotypically distinct
section, emerge only from explanted cranial neural fold epithelium
in vitro and that are not present in cultures of explanted trunk
neural tube explants under identical culture conditions
[(Newgreen and Thiery, 1980); see above and Breau et al. (2008);
Weston et al. (2004)]. Importantly, the morphology of this
Fig. 8. Matrix metalloproteinases (MMPs) are expressed in somites and branchial
arch mesenchyme. Molecular expression patterns of gene products, such as
ADAM13 mRNA, are characteristic of mesodermally derived mesenchymal cells,
as well as branchial arch mesenchyme, but have been uncritically described as
putative markers of Neural Crest-derived cells. (A) ADAM 13 mRNA expressing in
putative Neural Crest cells (arrows) in a stage-20 embryo of Xenopus laevis.
Arrowhead indicates the optic vesicle. (B) Lateral views of an early tailbud (stage
22) embryo (top) and a late neural (below) to show ADAM 13 protein in somitic
mesoderm (arrowhead). Arrows indicate putative Neural Crest cells in the late
neurula.
Source: Adapted from Hall (1999). All rights reserved. Original source: Alfandari
et al. (1997). http://dx.doi.org/10.1006/dbio.1996.8458. Reproduced with permis-
sion from Elsevier. Copyright© 1997 Academic Press. All rights reserved.
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FN-producing ﬁbroblastic cell population differs signiﬁcantly from
the small stellate appearance of “authentic” Neural Crest-derived
cells under identical culture conditions, and these ﬁbroblastic cells
appear to emerge precociously (before Neural Crest-derived cells
have segregated from the dorsal neural epithelium) from the
lateral non-neural epithelium of the Neural Fold (see Figs. 10–12).
The neural fold origin of such mesenchyme was initially inferred
by Nichols (Nichols, 1981, 1986), who showed that cranial mesench-
ymal cells in mammalian embryos were speciﬁcally and differentially
stained by Toluidine blue only when matrix GAGs had been
precipitated in situ by the presence of cetyl-pyridinium chloride
(CPC) in the histological ﬁxative [see Pratt et al. (1975)]. Remarkably,
these cells were seen adjacent to the lateral neural fold epithelium
(Fig. 10) beginning when the neural folds were splayed open
ventrolaterally, and more selectively stained cells were observed as
the neural folds elevated medio-dorsally. Careful analysis of the
appearance of the folds at progressive stages of elevation suggested
that newly emerged mesenchymal cells were from the neural fold
epithelium and were left behind as the folds continued to elevate.
Thus, as a consequence of these morphogenetic events, mesenchy-
mal cells seem to array in a progressive manner such that the earliest
cells to emerge are located in the most ventral locations, and later-
emerging cells in more dorsal locations. It is important to note,
moreover, that the ventral-to-dorsal distribution of mesenchymal
cells is accomplished well before the dorsal ridges of the neural folds
meet in the midline and fuse to form the neural tube, which suggests
that these mesenchymal cells are deposited directly into the matrix-
ﬁlled spaces, and remain there, rather than migrating ventrally from
a more dorsal location, as has often been inferred in the literature. It
is also noteworthy that these cells appear to emerge from the
elevating neural fold epithelium below a transient groove on the
epithelium's outer surface, which bears a remarkable resemblance to
the primitive streak—the site where, earlier in development of
amniote embryos, mesodermal cells originate from the embryonic
epiblast during gastrulation [Fig. 11; see also Waterman (1976)].
Although Nichols referred to these cranial mesenchymal cells as
“Neural Crest”—based on Hörstadius' (Hörstadius, 1950) operational
deﬁnition—this interpretation was revisited by Breau et al. (2008),
who showed that mesenchyme emerges from E-cadherin-expressing
non-neural epithelium of the lateral neural folds of mouse embryos
and enters directly into what becomes the branchial arches [Fig. 13;
see Breau et al. (2008); compare Fig. 10]. Since this neural fold
epithelium appears to be phenotypically distinct from the epithelium
of the dorsal ridges, and since mesenchymal cells appear to emerge
from the epitheliumwell before the authentic Neural Crest forms, the
idea that these early mesenchymal cells originate from the Neural
Crest was again called into question.
In a recent effort to assess whether mesenchymal cells that initially
populate the developing branchial arches originate from a domain of
neural fold epithelium distinct from the Neural Crest, DiI was
deposited on the outer surface of the neural fold epithelium lateral
to the dorsal ridges before they had fused to form the neural tube (Lee
et al., 2013b). Care was taken to deposit the dye only on superﬁcial
cells of the epithelium, and not to inject it beneath the epithelium
Fig. 9. After epithelial–mesenchymal transition (EMT) of Neural Crest epithelium, Neural Crest-derived mesenchymal cells enter the Migration Staging Area (MSA)—an ECM-
containing interstitial space delimited by neural, epidermal and “at trunk axial level” somite epithelia. Left: Fate-restricted and partially fate-restricted Neural Crest-derived
cells (see also Fig. 22) reside in close proximity and can interact with each other in the MSA before they disperse on interstitial migration pathways. Initially, some early
migrating neurogenic and gliagenic cells move between epithelial somites to contribute to components of the autonomic nervous system (top diagram). After the sclerotome
portion of the epithelial somites undergoes EMT, Neural Crest-derived neurogenic and gliagenic precursors begin to migrate ventrally amongst these somite-derived
mesenchymal cells and, ultimately, coalesce to form dorsal root ganglia (middle diagram). Finally, Neural Crest-derived pigment cell precursors migrate on a dorsolateral
pathway (bottom). Fate-restricted precursors that fail to disperse in a timely way on an appropriate migration pathway appear to undergo apoptosis (dashed circles). (D/M,
dermomyotome; NC, Neural Crest-derived mesenchyme; open circles, putative neurogenic precursors; solid circles, differentiated sensory neurons; hatched circles,
differentiated sympathoadrenal cells; open diamonds, glial/melanocyte precursors; solid diamonds, melanocyte precursors). Right: SEM photograph of a mouse embryo
trunk segment, after removal of epidermal epithelium to reveal underlying structures. Premigratory crest-derived mesenchymal cells can be seen in the interstitial space
between the neural tube and somite epithelia.
Source: Image on Right reproduced from Weston (1991) with permission from Elsevier. Copyright© 1991 by Academic Press, Inc. All rights of reproduction in any form
reserved.
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where existing mesenchymal cells or underlying neural epithelium
might be unintentionally labeled. With this labeling protocol, DiI-
labeled mesenchymal cells that were eventually detected in under-
lying spaces, could have originated by EMT only from the superﬁcial
epithelium itself. The results convincingly demonstrated that the
labeled mesenchymal cells, which derived from the lateral non-
neural epithelium (Fig. 14), were present in thematrix-ﬁlled interstitial
spaces beneath the neural fold epithelium. Importantly, these results
differed from those of earlier cell tracking studies (Kulesa and Fraser,
2000) in which cells marked by injecting DiI into the lumen of the
closed neural tube revealed an extensive later migration of labeled
cells into the branchial arches. We suggest that many of the late-
migrating cells seen in the posterior branchial arches were, most likely,
Neural Crest-derived neurogenic precursors of the enteric nervous
system on their migration pathway into the developing gut [see
Ciment and Weston (1983, 1985)]. In contrast, DiI marking of cells
on the surface of the lateral non-neural epithelium of the neural fold
conﬁrmed previous conclusions (Breau et al., 2008), and were
consistent with the initial inferences of Nichols (Nichols, 1981, 1986).
Moreover, the time-lapse analysis of DiI-labeled cells initially present
in the lateral non-neural epithelial domain of the avian neural fold
further conﬁrmed that, although there is some dorsal movement of
parts of this epithelium as the folds elevate and the lateral non-neural
epithelium overlaps the neural epithelium in the dorsal ridges, in
avian andmammalian embryos, many if not most of the mesenchymal
cells that emerge from this epithelium enter directly and progressively
into the underlying ECM-containing interstitial spaces [Figs. 12 and 13;
also see Suppl. Movie in Lee et al. (2013b); http://dev.biologists.org/
content/140/24/4890.full.pdfþhtml?with-ds=yes]. These cells do not
appear to migrate ventro-laterally from more dorsal locations, as had
been inferred and described in the classical and “neo-classical”
literature [see, for example, Fig. 2 in Imai et al. (1996); Noden
(1991); Fig. 1 in Dupin et al. (2010); and the poster insert in the
prominent review by Mayor and Theveneau (2013)]. It is not yet clear
if the same progressive emergence of mesenchymal cells occurs
during amphibian neurulation, largely because the process has not
been examined at appropriate spatial resolution or at appropriately
early stages of neural fold elevation. However, we predict that
mesectoderm formation in this system will resemble the events in
the cranial neural folds of avian embryos, and might also occur in the
trunk neural folds, where early-emerging mesenchyme from lateral
non-neural epithelium of the neural folds might be expected to
contribute to dorsal ﬁn connective tissue.
Neural Crest epithelium and lateral non-neural epithelium
of neural folds are phenotypically distinct
As suggested above, the cranial neural folds and the trunk neural
tube are structurally different, and it would be misleading to assume
Fig. 10. Mesectodermal cells appear progressively in the mesenchyme adjacent to the non-neuronal epithelium during cranial (midbrain/rostral hindbrain) neural fold
elevation. Transverse sections of neural folds from 3–12 somite embryos (noted in the corresponding tracings of the photographs) are reproduced at the same magniﬁcation
and aligned relative to the developing pharynx to illustrate progressive stages of neural fold elevation. The embryos had been ﬁxed to preserve matrix components produced
by mesectodermal cells, which allows the cells to be selectively and differentially stained with Toluidine blue. Note that darkly-stained cells appear to emerge from the
epithelium, and are left behind in the underlying interstitial space as the dorsal ridges of the neural folds elevate toward the embryonic midline, eventually to fuse and form
the neural tube. These mesenchymal cells presumably proliferate rapidly to ﬁll the interstitial space, which we suggest becomes the functional equivalent, at cranial axial
levels, of the Migration Staging Area (MSA) illustrated in Fig. 9 for trunk axial levels. http://dx.doi.org/10.1002/aja.1001760210.
Source: Reproduced from Nichols (1986) with permission from John Wiley & Sons. Copyright© 1986 Wiley-Liss, Inc.
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that the two embryonic epithelia are developmentally comparable
tissues when mapping their developmental potential. Before we
discuss this assertion further, it will be useful to consider three
salient issues: (1) that Neural Crest and lateral non-neural epithelia
of the cranial neural folds are phenotypically different; (2) that the
latter shares cellular phenotypes with mesodermally derived somite
epithelium; and (3) that the EMT that occurs in these two epithelial
domains are temporally and spatially distinct events that result in
the emergence of independently motile, but developmentally dis-
tinct, mesenchymal cell populations.
Cadherin expression patterns differ in neural and non-neural
epithelial domains of the cranial neural folds
The most striking difference between the medial neural and
the lateral non-neural epithelia is that the non-neural epithelium
expresses E-cadherin at high levels, whereas the dominant adhe-
sion protein in the adjacent neural epithelium is N-cadherin
[Figs. 4 and 5; Breau et al. (2008); Lee et al. (2013b); Weston
et al. (2004)]. We have already suggested how these two cadherins
might play a crucial role in the initial segregation of neural and
epidermal epithelia during neurulation.
These two epithelial domains of the early cranial neural folds can
be distinguished also by other molecular expression patterns. Mole-
cular markers of EMT and of the subsequent dispersal of mesench-
ymal cells [such as MMPs (Fig. 8), Snail, FoxD3, and Sox9] are co-
expressed with E-cadherin in the non-neural epithelium of the
cranial neural folds. Yet, these expression patterns are essentially
absent in the trunk neural tube as well as in the neuroepithelial
domains of the cranial neural fold that is positive for N-cadherin and
Sox1 [see Lee et al. (2013b); Fig. 5].
Fibronectin (FN)
Trunk Neural Crest-derived cells, present in the outgrowths from
explanted neural tube segments in vitro, do not produce FN (Newgreen
and Thiery, 1980; Rovasio et al., 1983). However, two distinct popula-
tions of cells are present in outgrowths from cranial neural fold
explants (Newgreen and Thiery, 1980). The initial outgrowth of cells
with ﬁbroblastic morphology is seen to produce FN, whereas a second
population of cells, with a distinct small stellate morphology in the
same culture conditions reminiscent of cells in the outgrowth of trunk
neural tube explants, do not express FN. It is tempting to suggest that
the former population originates from the lateral non-neural epithelial
component of the neural fold explant, whereas the latter arises from
the Neural Crest epithelium, which eventually segregates from the
dorsal neural epithelium of the neural tube. This notion remains to be
tested by lineage tracing in vitro (Luo et al., 2003). Interestingly,
although FN expression has been reported to be localized to this dorsal
neural fold epithelium [Fig. 15; (Mittal et al., 2010)], the ﬁgures appear
to support the idea that FN expression is restricted to the thin
epithelium overlying the dorsal ridge of the neural fold, as well as in
more ventral non-neural epithelium of the branchial arch, both of
which are known to express E-cadherin [(Breau et al., 2008; Weston
et al., 2004); compare Fig. 4 with Fig. 15)].
Integrins
The roles of integrins—receptors of various ECM components,
including FN, used by migrating Neural Crest-derived cells—are
bafﬂingly complex [see McKeown et al. (2013)]. However, the
integrins expressed in the two epithelial domains of the neural
fold appear to be distinct. Integrin αvβ3, for example, is expressed
in lateral neural fold epithelium but does not appear to be
expressed in the thickened neural epithelium of the neural folds
or by authentic trunk Neural Crest-derived cells. In contrast,
authentic Neural Crest-derived cells seem to depend on the
function of β1-containing integrins for the normal development
of neural derivatives [(Alfandari et al., 2003; Breau et al., 2009,
2006; Pietri et al., 2004); see also McKeown et al. (2013) and
Wehrle-Haller (2006)].
Mesodermal markers
Other gene products characteristic of mesodermally derived
cells are also expressed in the cells of the lateral non-neural
epithelium and in cranial mesenchyme. One such gene product
encodes a proteoglycan link protein that is characteristic of
chondrogenic cells [Fig. 16; Colas and Schoenwolf (2001)] and
appears speciﬁcally in the lateral neural fold epithelium, which is
known to co-express E-cadherin, but not in the medial neural
domain of the cranial neural folds.
Fig. 11. A transient groove in the forebrain–midbrain neural fold of a 5-somite
mouse embryo resembles the embryonic primitive streak and appears to be the site
of emergence of mesectodermal cells into the interstitial space underlying the
elevating cranial neural folds. The photographs labeled 6A and 6B are SEM images
of forebrain (FB)–midbrain (MB) neural folds. The photograph labeled 8B is a
parasagittal section of a slightly younger (4-somite) embryo, roughly corresponding
to the region indicated by the dashed outline in 6B. Notice the differentially-stained
cells that seem to enter the interstitial space below the groove denoted by the
arrow in 6B and 8B. It is important to emphasize that this apparent involution
process occurs well before the dorsal ridges of the neural folds fuse to form the
dorsal epithelium of the neural tube, from which “authentic” Neural Crest
epithelium will eventually be partitioned.
Source: Reproduced from Nichols (1981) with permission from Development, The
Company of Biologists.
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Two genes, characteristic of mesodermally derived skeletogenic
cells, are particularly informative for distinguishing the two
epithelial domains of the neural folds. One gene encodes PDGFRα
(Takakura et al., 1996; Weston et al., 2004) and the other encodes
the regulatory protein, Twist (Gitelman, 1997). PDGFRα is clearly
co-expressed with E-cadherin in the non-neuronal epithelial
domain of the cranial neural folds (see wholemount embryo and
panel bʺ in Fig. 4), and in branchial arch mesenchyme. Twist is also
expressed in the mesenchymal cells that enter the adjacent
branchial arches [Fig. 17; (Alfandari et al., 2003; Gitelman, 1997;
Soo et al., 2002)]. Analyses of the expression and function of
PDGFRα and Twist have been particularly useful in deﬁning the
properties of skeletogenic mesenchyme in the head and branchial
arches of vertebrate embryos. For example, the Patch mouse
mutant (Grüneberg and Truslove, 1960), which harbors a deletion
in the gene encoding PDGFRα (Stephenson et al., 1991), was
initially thought to be potentially informative with respect to
lineage segregation within Neural Crest-derived cells, since it
affected the development of both melanocytes and craniofacial
skeletal derivatives (Morrison-Graham et al., 1992). A detailed
analysis of the developmental defects in embryos homozygous for
this mutation, however, revealed that it adversely affects somite
development as well as skeletal and connective tissue structures
derived from mesectoderm, including the craniofacial skeleton,
corneal stroma, the cardiac outﬂow tract, and mesenchyme
components of glandular tissue. In contrast, no cell-autonomous
defects were observed in neural or pigment derivatives of the
Neural Crest in these mutant embryos (Morrison-Graham et al.,
1992; Schatteman et al., 1992; Wehrle-Haller et al., 1996).
As with the loss of PDGFRα function, the loss of Twist function
causes defects in branchial arch formation, but no changes in
“authentic” Neural Crest derivatives were noted (Soo et al., 2002).
Such “paradoxical” phenotypes in the two mutants would not be
expected if, as predicted, the mutation occurred in a gene that
functioned in a common Neural Crest-derived precursor of neural,
pigment and skeletogenic lineages. Instead, the ﬁndings from
these studies support the inference that skeletogenic mesenchyme
in the head and branchial arches originates primarily, if not solely,
in an epithelial domain of the cranial neural folds that is spatially,
temporally, and developmentally distinct from the authentic
Neural Crest. This inference was ﬁnally conﬁrmed by careful cell
lineage marking studies that discriminated between cells originat-
ing from the two epithelial domains [Fig. 14; (Lee et al., 2013)].
A Lateral non-neural epithelial domain of the cranial neural
folds—“Metablast”—is developmentally distinct from
the epithelial neural crest
Lineage marking studies
Schilling and Kimmel (Schilling and Kimmel, 1994) originally
reported that what they called “premigratory Neural Crest cells”
already included fate-restricted cranial and branchial arch skeletogenic
cells that had dissociated from its originating epithelium. Surprisingly,
although detailed lineage marking experiments were performed
(Fig. 18), the location of a common precursor for mesectoderm and
other Neural Crest derivatives was not explicitly identiﬁed. What the
tabulated results in this ﬁgure do show, however, is that skeletogenic
cells arise from an epithelial domain that is spatially distinct from the
domain that gives rise to neurogenic and melanogenic derivatives of
authentic Neural Crest (see also Fig. 19). Consistent with this
Fig. 12. Well before the dorsal ridges of the neural folds fuse to form the dorsal neural tube, mesenchymal cells expressing β-gal activity emerge from lateral non-neural
epithelium of cephalic neural folds in e8.5 Ht-PA-Cre/R26R transgenic mouse embryos. The dorsal ridge of the cranial neural fold is indicated by the dashed lines in panels
A-C. (A) Labeled mesenchymal cells are present in the interstitial spaces of the branchial arch (white arrowheads in (B)), the frontonasal process (red arrowhead) and around
the optic pit (black arrowheads; in panel C) before any marked cells are detected in the neural epithelium of the dorsal ridge or the neural tube (D).
Source: Reproduced with permission from Breau et al. (2008). Copyright (2008) National Academy of Sciences, U.S.A.
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conclusion, these skeletogenic cells do not appear to express the
Crestin gene product, which has been posited to be a “pan-Neural
Crest” marker in zebraﬁsh embryos (Luo et al., 2001; Rubinstein et al.,
2000), and which is expressed by Neural Crest-derived cells and in
their neural, glial, and pigment cell derivatives that reside in the MSA
of amniote embryos.
Gene regulatory networks distinguish two epithelial domains
The skeletogenic mesenchyme that ultimately enters the nas-
cent pharyngeal arches gives rise to skeletal components of the
jaw and gills and is thought to up-regulate mesectoderm-speciﬁc
genes such as dlx2a and ﬂi1a (Brown et al., 2000), which are
components of a regulatory pathway that also includes the
characteristic mesodermal marker, Twist1 (see above). Consistent
with this inference, the function of Twist1 in mice is required for
normal differentiation of cranial skeletal structures and cardiac
outﬂow track connective tissue (Soo et al., 2002; Vincentz et al.,
2013). It should be noted that, based on their earlier work on the
development of the cardiac outﬂow track (Vincentz et al., 2008),
Vincentz and coworkers considered the possibility that loss of
Twist function results in a change in cell fate from mesectodermal
to neural in cardiac Neural Crest-derived cells. Their results seem
to suggest that Twist function can act to repress sympathetic
neural regulatory pathways in post-migratory cells by antagoniz-
ing BMP targets. However, because these lineage markers do not
distinguish Neural Crest-derived cells from that of mesenchymal
cells that precociously enter embryonic interstitial spaces after
emerging from the lateral non-neural epithelium of the cranial
neural folds, it cannot yet be known which cell population is
affected by altered Twist function.
Recently, an impressive series of genetic marking and pertur-
bation studies in zebraﬁsh embryos by Das and Crump (Das and
Crump, 2012) have provided compelling evidence for the gene
regulatory pathway illustrated in Fig. 19. In this pathway, Twist1 is
expressed in mesectoderm precursors and functions to promote
Fli1a and Fgf function, which, in turn, regulate Dlx2a function and
leads to mesectoderm differentiation into jaw and gill cartilages. In
contrast, BMP signaling in an adjacent epithelial domain [see also
Aybar and Mayor (2002)] promotes Id2a function, which sup-
presses Twist1. Although the gene regulatory pathway inferred by
these authors might, as they suggest, account for the segregation
of skeletogenic cells and cells with neurogenic potential from a
common Neural Crest-derived lineage precursor, their proposed
pathways do not exclude the possibility that two distinct epithelial
domains can be established, and that the boundary between the
two domains can be maintained by BMP signaling [see also the
thoughtful discussion in Kanzler et al. (2000)]. Indeed, their
suggested regulatory mechanism seems to provide a clear way
to establish and maintain such adjacent epithelial domains with
distinctly different developmental potentials and fates.
Another compelling paper from the same laboratory (Cox et al.,
2012) suggests an epigenetic mechanism for establishing
mesoderm-like developmental potential in the epithelium that
produces the mesectoderm precursors of the vertebrate head.
Their proposed mechanism (Fig. 20) involves modiﬁcation of
Fig. 13. Ht-PA-Cre–expressing cells emerge directly into underlying embryonic interstitial spaces from non-neural epithelium that co-expresses E-cadherin. Sections through
midbrain neural folds of an e8 (4–5 somite) embryo. (C, G) Red arrowheads indicate cells of the non-neural epithelium that co-express Cre and E-cadherin. White
arrowheads mark instances of Cre-expressing mesenchyme that also expresses weak cytoplasmic E-cadherin immunoreactivity. Blue arrowheads show cells that appear to
be down-regulating cell-surface E-cadherin during epithelial to mesenchymal transition (EMT), and presumably, as a consequence (Dady et al., 2012) intermingling with
neural cells of the medullary plate. (D, H) Low-magniﬁcation sections shown for orientation. Planes of section are indicated in the right panels by black (solid or dashed)
lines, and the red segments indicate the location of double-positive, non-neural epithelial cells in the neural fold domains lateral to the dorsal ridge.
Source: Reproduced with permission from Breau et al. (2008). Copyright (2008) National Academy of Sciences, U.S.A.
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Fig. 14. Two epithelial domains of the cranial neural folds give rise to distinct cellular derivatives. (A, A0) DiI-labeled cells on the surface of lateral non-neural epithelium in
early (4 somites) chicken embryos undergo EMT and produce branchial arch, as well as periocular, mesenchyme. As expected, these labeled mesenchymal cells express
TFAP2a, which is normally present in mesectodermal cells and is required for normal skeletogenic development. Conversely (D, D0), when neural epithelium is labeled with
DiI by injection of the dye into the lumen of the closed neural tube of 7-somite chicken embryos, no labeled cells are detected in branchial arch mesenchyme, whereas
numerous labeled cells were present within Trigeminal ganglia (dotted lines in D0). http://dx.doi.org/10.1242/dev.094680.
Source: Reproduced from Lee et al. (2013b) with permission from Development, The Company of Biologists.
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the chromatin structure with histone variant H3.3. Although the
authors still refer to “cranial Neural Crest” as the origin of the
mesectoderm and the target of this modiﬁcation, their model,
again, does not exclude the possibility that such an epigenetic
event could establish a distinct epithelial domain adjacent to
authentic Neural Crest epithelium at early developmental stages
of zebraﬁsh development.
The non-neural domain of cranial neural folds should be explicitly
distinguished from the Neural Crest
Several attributes of the lateral non-neural epithelium
suggest that its developmental potential differs from that of Neural
Crest: (1) this epithelial domain expresses phenotypic traits
characteristic of mesoderm; (2) when this domain undergoes
EMT in amniote embryos, mesenchymal cells appear to undergo
involution through a transient structure that bears remarkable
similarity to the primitive streak (or blastopore) and appears at an
earlier developmental stage in the embryonic epiblast [Fig. 11;
(Nichols, 1981, 1986)]; and (3) the mesenchymal cells that result
from this involution express phenotypic traits characteristic of
somite-derived mesenchymal cells at trunk axial levels.
To help distinguish the neural epithelium in the dorsal ridges of
the neural fold from lateral cranial neural fold epithelium [pre-
viously called “paraneural” epithelium; see Johnston (1966);
Fig. 15. Fibronectin (FN) is expressed by cells in the non-neural epithelial domain of the cranial neural folds. (D) In situ hybridization shows that FN mRNA is expressed in the
dorsal ridges of the neural fold in whole mount 8–10 somites mouse embryos (arrows), as well as at more rostral axial levels. (E) Transverse sections reveal that this
expression is present both in lateral ectoderm associated with the pharynx and in the dorsal ridges of the neural fold. The enlargement of the dorsal ridge region (dashed
rectangle) reveals that expression is restricted to lateral non-neural epithelial cells closely overlying the neural epithelium. Asterisks mark FN mRNA expressed by the dorsal
neural ectoderm (long arrow in the inset) and the surface nonneural ectoderm (arrowhead in inset). (F) Consistent with this interpretation, FN immunostaining (green) in
the dorsal ridge is associated with TFAP2A-positive cells (arrow, neural; arrowhead nonneural; inset). These cells are considered to originate from “cranial Neural Crest” but
are more likely to have emerged from overlying non-neural (Metablast) epithelium (compare the pattern of E-cadherin staining seen in similar histological sections in
Fig. 4B, C, and the E-cadherin/Snail co-expression in Fig. 5C). Abbreviations: A, atrium; NT, neural tube; ec, endocardium; g, gut.
Source: Reproduced from Mittal et al. (2010) with permission from Elsevier. Copyright© 2010 Elsevier Ireland Ltd. All rights reserved
Fig. 16. A proteoglycan link protein, characteristic of mesoderm-derived chondro-
genic cells, is differentially expressed in the lateral, non-neural epithelium of the
neural fold. (A, B) Whole-mount and section (level of dotted transverse line in (A),
showing an embryo labeled with a riboprobe for the proteoglycan link protein. This
differential expression of a gene product involved in chondrogenesis is consistent
with the suggestion that lateral non-neural epithelium of the neural fold is the
source of chondrogenic mesenchyme in the head.
Source: Reproduced from Colas and Schoenwolf (2001) with permission from John
Wiley & Sons. Copyright© 2001 Wiley-Liss, Inc.
Fig. 17. Twist is expressed in the branchial arches and craniofacial mesenchyme. The
Twist gene is thought to regulate development of mesodermal derivatives in vertebrates.
In Xenopus embryos, expression of the XTwist gene product appears in head and
branchial arch mesenchyme, and in mesodermally-derived structures, but not in
authentic Neural Crest derivatives. Abbreviations: Wd, wolﬁan-duct; pn, neural plate;
e, eye; ot, otic vesicle. http://dx.doi.org/10.1016/S0012-1606(03)00277-X.
Source: Reproduced from Alfandari et al. (2003) with permission from Elsevier. Copy-
right© 2003 Elsevier Inc. All rights reserved
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Weston (1970)] and to emphasize the distinct phenotypic and
functional attributes of this latter epithelial domain, we have given
this latter epithelium a new name, “Metablast” (meta-; “occurring
later than, or in succession to [Epiblast]”) (Weston et al., 2004); see
also Breau et al. (2008). Unlike cells derived from dorsal neural
epithelium, the so-called Metablast-derived cells have now been
Fig. 18. Putative “premigratory” Neural Crest cells in the head of early zebraﬁsh embryos are fate restricted. (A, B) Although the authors deﬁne these “premigratory”
mesenchymal cells as “Neural Crest”, their actual origin is not clear. Operationally, tiers of cells at or near the surface of the epithelium lateral to the neural keel—designated
by the numbers in the region outlined on the Nomarski optics photograph of a live 12-h embryo (A) and enlarged in (B), and determined by counting cell diameters between
a labeled cell and the lateral margin of the “premigratory” mass—were injected with a lineage tracing dye and the developmental fates of labeled cells were followed.
Presumably, these numbered tiers proceeded from lateral to medial along the surface of the mass of cells designated “nc” in the accompanying transverse section. Whatever
their actual origin, the tabulated results clearly demonstrate that skeletogenic cells (designated C in the Table) arise from a lateral epithelial domain that is spatially distinct
from the domains that give rise to the neurogenic (N) and melanogenic (P) derivatives of authentic Neural Crest. CT, connective tissue; U, unknown or undifferentiated.
Source: Reproduced from Schilling and Kimmel (1994) with permission from Development, The Company of Biologists
Fig. 19. Distinct molecular regulatory pathways establish and maintain Neural
Crest and ectomesenchymal epithelial domains. This regulatory scheme was
originally proposed by Das and Crump (2012) as a way to establish a multipotent
cranial Neural Crest population (at 12 h), and then a population of ectomesench-
yme precursors (at 16 h), after they “delaminate from the neuroepithelium and
migrate away from the source of BMP signal.” However, based on inferences
summarized in Fig. 18 from Schilling and Kimmel (1994), it is not clear if such cells
actually ever delaminate from neuroepithelium. Moreover, as indicated in the
portion of the scheme illustrated here, this same regulatory mechanism can equally
well account for the establishment and maintenance of distinct, contiguous
epithelial domains, Neural Crest and Metablast, regulated by precisely localized
BMP signaling. http://dx.doi.org/10.1371/journal.pgen.1002710.
Source: Adapted from Das and Crump (2012)
Fig. 20. An epigenetic mechanism to establish a distinct epithelial domain, like
Metablast, with skeletogenic potential. This regulatory scheme, also proposed by
members of the Crump laboratory (Das and Crump, 2012), suggests that altering
chromatin structure by H3.3-dependent histone replacement could provide a way
for a developmentally distinct epithelial domain with skeletogenic potential to be
established in an ectodermal epithelium. Signiﬁcantly, the authors acknowledge
that the extent to which ectomesenchyme derivatives (e.g., head skeleton) and non-
ectomesenchyme derivatives (e.g., pigment, glia and neurons) derive from a
common multipotent precursors remains unresolved. http://dx.doi.org/10.1371/
journal.pgen.1002938.
Source: Reproduced from Cox et al. (2012)
J.A. Weston, J.P. Thiery / Developmental Biology 401 (2015) 37–61 53
shown by lineage tracing to be a signiﬁcant source of branchial
arch mesenchyme [Fig. 14; (Lee et al., 2013b)]. Accordingly, rather
than the precocious and prolonged process of emergence of Neural
Crest-derived mesenchymal cells that was previously thought to
occur at cranial axial levels, the early segregation of Metablast-
derived mesenchyme might more informatively be considered a
delayed morphogenetic event resembling gastrulation. This
morphogenetic process, like gastrulation, produces a distinct
population of mesenchymal cells with cellular phenotypes and
developmental fates similar to those of mesoderm. As suggested
schematically in Fig. 21, this population of cells enters the cranial
MSA and the branchial arches before authentic Neural Crest-
derived cells do so, and thereby can possibly set the stage for
subsequent migration of Neural Crest-derived cells into and
through the branchial arches.
The reinterpretation of the temporal events suggested in Fig. 21
conforms with the inferences (1) that classical experimental
results were derived from cell/tissue marking and transplantation
that involved both the lateral neural fold (Metablast) epithelium
and the dorsal ridges of the neural folds, which contained
authentic Neural Crest epithelium; (2) that skeletogenic mesench-
ymal cells segregate from the Metablast domain of the lateral
Fig. 22. After epithelial to mesenchymal transition (EMT), cells that emerge from
neural fold epithelial domains undergo progressive fate-restriction. In this scheme,
based on various lineage analyses, and ﬁrst proposed about 25 years ago,
mesectodermal cells with skeletogenic and connective tissue developmental
potential (newly-labeled MB for Metablast) are shown segregating precociously
from cranial neural fold epithelium. Subsequently, fate-restricted neurogenic
precursors, populations of partially restricted neuro-glial, and glia–melanocyte
precursors, and ﬁnally, fate-restricted glial and melanocyte precursors appear
within the Neural Crest-derived cell populations. Although they reside in close
proximity in the MSA (see Fig. 9), these subpopulations can interact, and respond to
speciﬁc environmental cues that can cause them to survive or undergo lineage
restrictions or apoptosis, proliferate, or initiate directed migration on appropriate
interstitial pathways. Dashed lines indicate contact-mediated interactions between
fate-restricted neurogenic precursors and partially-restricted glial-melanocyte
precursors that elicit gliagenesis. Similar interactions between partially-restricted
glial and neuron progenitors can also elicit neurogenesis (see Dyachuk et. al., 2014;
Espinosa-Medina et al., 2014). Abbreviations: a, autonomic neuronal precursors; A,
adrenergic neurons; C, cholinergic neurons; cnf, cranial neural folds; E, enteric
neurons; em, ectomesenchyme; G, Schwann sheath and other peripheral glia; M,
melanocytes; MB, Metablast; nc, trunk Neural Crest (and cranial Neural Crest after
fusion of the neural folds in the dorsal midline); nf, neural folds after the
ectomesenchymal subpopulation has segregated; nn nonneurogenic crest cells;
np, neurogenic precursors; SNp, primary sensory neurons; SN, other sensory
neurons. Redrawn from Weston (1991) with permission from Elsevier. Copyright©
1991 by Academic Press, Inc. All rights of reproduction in any form reserved.
Fig. 21. Schematic representation of the complexity of domains in cranial neural
fold epithelium. (A) Summary diagram of the approximate location of putative
Metablast epithelium (green) in cranial neural folds. (B) A generalized temporal
representation of the initial location of Metablast epithelium (a); the progressive
elevation of neural folds to form dorsal ridges with lateral non-neural epithelium
superimposed upon neural epithelium (b, c); the precocious emergence of
Metablast-derived cells into underlying interstitial spaces (b)–(d); and, ﬁnally,
the onset of EMT by authentic Neural Crest-derived cells into the interstitial spaces
containing Metablast-derived mesenchyme (d). In this diagram, the red circles
represent E-cadherin-expressing, non-neural epithelial cells; the green circles
represent Metablast cells that co-express E-cadherin and PDGFRα; and the blue
circles represent “authentic” Neural Crest cells. Reproduced with permission from
Breau et al. (2008). Copyright (2008) National Academy of Sciences, U.S.A.
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cranial neural folds before cells with Neural Crest potential have
been partitioned from the neural epithelium [see Figs. 12 and 13;
Lee et al., (2013b)]; and (3) that authentic Neural Crest-derived
cells require appropriate FN-containing matrix substrata before
they enter adjacent interstitial spaces. The recent report that trunk
Neural Crest-derived cells in the zebraﬁsh embryo are not the
source of ﬁn skeletal components (Lee et al., 2013a) is also
consistent with the generalization that authentic Neural Crest-
derived cells lack skeletogenic potential.
To be recognized as a valid alternative source of skeletogenic
cells, the proposal that Metablast epithelium is a distinct
embryonic structure from authentic Neural Crest must address
some signiﬁcant counter-arguments
There are, as one might expect, a number of plausible objec-
tions that have been raised against our suggestion that authentic
Neural Crest is not the source of skeletogenic mesenchyme.
The inference that trunk Neural Crest-derived cells have skeletogenic
potential is based on problematic cell culture results.
McGonnell and Graham (Graham, 2004; McGonnell and
Graham, 2002) reported that cultured avian trunk Neural Crest-
derived cells could give rise to cells exhibiting phenotypes char-
acteristic of skeletal/connective tissue. This seemed to suggest that
Neural Crest-derived cells do have skeletogenic potential. How-
ever, in these experiments, the source of “Neural Crest” was
actually cultured neural fold epithelium from early avian embryos.
This neural fold epithelium was explanted and maintained in vitro
at high cell densities for prolonged times in an enriched culture
environment. Consequently, in such long-term cell culture experi-
ments, it is likely that rare mesenchymal stem cells (Komada et al.,
2012; Takashima et al., 2007) in the cultured population are
“ampliﬁed” by environmental conditions that promote their sur-
vival and proliferation. Thus, it is difﬁcult to know the actual
source and the developmental history of the embryonic cells that
gave rise to the reported phenotypes. So, although the trunk
Neural Crest cannot be excluded as a source of skeletogenic cells,
it seems unlikely that these cells normally have skeletogenic
potential. Subsequently, it was suggested that Neural Crest-
derived cells respond to localized skeletogenic signals, such as
FGF, when they enter the Branchial Arches (BAs) (Blentic et al.,
2008). Although this study carefully describes the localization of
such signaling molecules in avian and zebraﬁsh embryos, and
reports that a Sox10-expressing, Neural Crest-derived cell popula-
tion is present in the BAs, their study lacked the temporal and
spatial resolution needed to exclude the possibility that skeleto-
genic cells originated from cells that had precociously entered the
BAs before the onset of the migration of Neural Crest-derived cells.
Cloning studies suggesting that neural and mesectodermal derivatives
have a common precursor are technically ﬂawed.
The results of limit-dilution cloning studies in vitro initially
appeared to refute our suggestion that neural and mesectodermal
derivatives do not originate from a common neural crest-derived
precursor (Barofﬁo et al., 1991; Ito and Sieber-Blum, 1991). These
cell culture results, however, are also subject to uncertainties
caused by cell culture and analytic protocols. These concerns have
been previously discussed (Breau et al., 2008; Henion and Weston,
1997; Weston et al., 2004) and are summarized as follows:
(1) Neural Crest-derived cell populations used for limit-dilution
clonal cultures were obtained from primary cultures of cells
derived from neural fold explants in rich culture medium. These
initial explants of mesencephalic neural folds would include
superimposed neural and non-neural epithelia, which are difﬁcult
or impossible to separate by microsurgery. (2) After primary
culture, enzymatically dissociated cells were diluted and cultured
at clonal densities in complex culture medium on feeder cell
substrata. (3) As with all such culture protocols, the culture
conditions not only result in the enrichment of rare cells with
stem cell abilities, but also, very likely, induced changes in the
developmental potential of responsive cells. (4) As the overall
cloning efﬁciency was not assessed, and since not all clones were
analyzed for their cellular phenotypes, the survey of the develop-
mental potential of the clonal progenitors was necessarily biased
(see the Fate-restriction and lineage diversiﬁcation in Neural
Crest-derived and Metablast-derived cell populations section)
and probably overestimated the proportion of skeletogenic pre-
cursors in the population. (5) Finally, the actual data, carefully and
responsibly summarized in Table 1 of their original paper (Barofﬁo
et al., 1991), showed dramatic variations in clone size generated by
progenitors under identical culture conditions, and the very few
clones that contained multiple Neural Crest-derived phenotypes as
well as mesectoderm-like derivatives were exceptional in that
they were two or three orders of magnitude larger than clones
that lacked multiple derivative classes.
As with the experiments of McGonnell and Graham, these
results could be explained by the selection of a rare mesenchymal
stem cell clonal progenitor [see Komada et al. (2012)]. Although a
follow-up paper (Dupin et al., 2010) still did not provide estimates
of cloning efﬁciency and, unfortunately, did not include informa-
tion about the sizes of clones that contained both skeletogenic and
neural cell types, the authors reasserted their conclusion that cells
with neural, melanocytic, chondrogenic and osteogenic potential
originated from a common Neural Crest-derived clonal precursor.
This conclusion might be valid for cells from mesencephalic neural
folds after prolonged culture in vitro. However, their cloning
methods do not provide an unbiased survey of the kinds and
proportions of fate-restricted precursors in the original cultured
cell population (see the Fate-restriction and lineage diversiﬁcation
in Neural Crest-derived and Metablast-derived cell populations
section) nor do they provide any insight concerning where such
cells originate in vivo. Consequently, their results cannot exclude
the possibility that clones containing skeletogenic mesectoderm
originate from a developmentally distinct precursor within cranial
neural fold epithelium.
The conclusion that regeneration of Neural Crest cells after
experimental ablation accounts for the presence of elements of head
skeleton ignores a more parsimonious explanation.
The presence of head skeletal components has been reported
after Neural Crest ablation at mid- and hindbrain axial levels
(Scherson et al., 1993). This result might be thought to support the
idea that skeletogenic precursors do not originate from Neural Crest.
However, the authors accounted for the presence of skeletal ele-
ments in the head by proposing that Neural Crest-derived skeleto-
genic cells regenerated from neuroepithelial cells remaining in the
lateral and ventral neural tube after ablation. Thus, Scherson and co-
workers ablated the dorsal neural tube at mid- and hindbrain axial
levels before the onset of Neural Crest migration. They reported that
the DiI-labeled mesenchymal cells that emerged after ablation from
lateral and ventral neural tube epithelium followed normal migratory
pathways, and that branchial arch structures were present in such
operated embryos. They concluded that neuroepithelium could
regulate their normal CNS fates to form Neural Crest derivatives,
including skeletogenic mesenchyme. This result [see also Saldivar
et al. (1997)] is based on the assumption that Neural Crest is the sole
source of skeletogenic mesenchyme and seems to conﬁrm that
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Neural Crest-derived cells produce skeletal elements in the branchial
arches. However, it should be noted that these experiments did not
show that DiI-labeled cells were present in the branchial arch
structures observed in operated embryos. Nor did the authors
consider the possibility that the dorsal neural tube ablations
described in these papers did not remove the lateral non-neural
epithelium or the mesenchymal cells that had precociously emerged
from it. Therefore, since such mesenchyme is known to precociously
enter into the branchial arches (Breau et al., 2008; Lee et al., 2013b;
Pietri et al., 2003), the possibility cannot be excluded that the
branchial arch structures, which are thought to arise from regener-
ated Neural Crest-derived cells, were actually formed from mesench-
ymal cells originating from embryonic tissue that had not been
removed in the operated embryos but were retained in the inter-
stitial spaces. This alternative is also consistent with later reports
from the same laboratory [see Fig. 1 in Baker et al. (1997)] that lateral
non-neural epithelium transplanted in these experiments included
mesenchymal cells that closely associated with, and likely originating
from, the grafted epithelium.
Putative genetic markers of NC, previously thought to be expressed
initially only in dorsal epithelium of the nascent neural tube, are also
expressed in lateral non-neural (Metablast) epithelium of the neural
folds.
Finally, it has been reported that skeletogenic mesenchyme is
robustly labeled in the head and branchial arches when cells are
speciﬁcally marked in transgenic mice by the expression of Cre-
recombinase driven by Wnt1 or Ht-PA-Cre promoters. Since Wnt1
has been assumed to be speciﬁcally and exclusively expressed in
the dorsal neural epithelium, it was inferred that these skeleto-
genic cells originated from Neural Crest-derived cells (Jeong et al.,
2004; Jiang et al., 2000; Pietri et al., 2003). A closer analysis of the
expression pattern of Wnt1, however, has revealed that it is
expressed not only in the medio-dorsal neural epithelium of the
neural tube but also in the lateral non-neural epithelium of the
neural folds (Breau et al., 2008). Likewise, as previously men-
tioned, the Ht-PA-Cre promoter would normally cause all cells that
disperse within interstitial spaces to be intrinsically marked,
regardless of their origin. Consequently, the assumption that
Neural Crest-derived cells are speciﬁcally and exclusively labeled
in these transgenic embryos is not valid, unless, of course, it is also
assumed that the lateral non-neural and medio-dorsal neural
epithelia are developmentally equivalent.
In summary, we believe that, even after considering these
counter-arguments, it is appropriate to question whether the
Neural Crest is the source of mesenchyme with skeletogenic and
connective tissue (smooth muscle, odontogenic, etc.) potential.
We also believe that it is still appropriate to consider the heuristic
alternatives: (1) that these mesoderm-like derivatives originate
from a distinct non-neural epithelial domain of the neural
folds in vertebrate embryos, and (2) that this epithelium under-
goes precocious EMT to produce mesenchyme that enters adjacent
interstitial spaces before migration of Neural Crest-derived cells
begins.
Fate-restriction and lineage diversiﬁcation in Neural Crest-
derived and Metablast-derived cell populations
Even if, as we have suggested, the epithelial Neural Crest is not
the source of common precursors of both skeletogenic and
neurogenic cell lineages, these cells still give rise to a remarkable
diversity of cell types. Accordingly, if our suggestion were accepted
that skeletogenic mesenchyme does not originate in the Neural
Crest, we would no longer need to postulate molecular regulatory
mechanisms that would account for the appearance of both neural
and skeletogenic phenotypes from a common precursor. Rather,
we could more tractably address and eventually understand the
mechanisms that progressively restrict the developmental poten-
tial of Neural Crest-derived cells to produce the still remarkably
diverse repertoire of neural, glial, glandular, and pigment cell
phenotypes diagramed in Fig. 22.
The starting point of such an analysis is the consensus that the
cells in the dorsal neural epithelium of the nascent trunk neural tube
are developmentally multipotent. This was clearly demonstrated by
the results of early lineage studies utilizing DiI as an externally
applied marker (Bronner-Fraser and Fraser, 1989). Although it was
initially claimed that this work provided direct evidence of Neural
Crest cell pluripotentiality, it now appears more likely that labeled
dorsal neuroepithelial cells in the trunk neural tube can give rise to
both neural tube and Neural Crest cell types. It is plausible to infer,
however, that when the Neural Crest is initially partitioned from the
dorsal neural tube epithelium, the cells within this epithelium are
multipotent, and eventually produce the remarkable range of neural,
endocrine, and pigment phenotypes generally attributed to authentic
Neural Crest.
Lineage diversiﬁcation is forestalled in epithelial cells coupled through
gap junctions
It is intriguing to note that the cells of the early Neural Crest
epithelium express Cx43, a member of a multigene family encoding
connexins (Kumar and Gilula, 1992). Connexins assemble to form gap
junctions, which are thought to mediate the functional coupling of
cells within epithelia (Bennett et al., 1991; Bruzzone et al., 1996), and
thereby coordinate cell communication involved in patterning and
differentiation during development (Guthrie and Gilula, 1989; Lo,
1996; Warner et al., 1992). Such gap junction-mediated cell commu-
nication exists in the neural tube and in Neural Crest within the
dorsal neural tube epithelium (Huang et al., 1998). Accordingly, it is
tempting to speculate that gene activity within such coupled
epithelium would be coordinated, and that developmental multi-
potentiality would be preserved in its cells by preventing differential
gene expression within the communicating epithelial domain.
Accordingly, we suggest that, while gap junctions and consequent
cell coupling are maintained, their homeostatic function would serve
as a “governor” to suppress lineage diversiﬁcation by the coupled
cells in the epithelium. This would presumably be mitigated when
cells began to dissociate from the epithelium under the control of
EMT regulatory pathways (see above). Additionally, one might
predict that the efﬁciency of EMT regulation itself and the resultant
emergence of mesenchymal cells from an epithelium would posi-
tively correlate with the level of connexin production and the degree
of cell coupling within the epithelium. This is exactly the result that
was observed and reported in vivo and in vitro (Ewart et al., 1997;
Huang et al., 1998). Cells within Neural Crest epithelia would be
expected to remain pluripotent until the regulated events of EMT
occurred and epithelial cell coupling was interrupted. This, too, is
consistent with reported observations (Bronner-Fraser and Fraser,
1989).
Fate-restricted NC-derived cells are detected soon after epithelial cells
undergo EMT
The progressive restriction of this developmental potential
would be predicted to begin only after the onset of EMT and the
separation of mesenchymal cells either from Neural Crest or
Metablast epithelium. This prediction has been validated in a
number of ways. First, monoclonal antibody technology revealed
the existence of numerous phenotypically distinct subpopulations
of Neural Crest-derived cells in vivo and in vitro (initially reviewed
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in Weston, 1983; see also Ciment et al., 1986; Girdlestone and
Weston, 1985; Marusich et al., 1986; Marusich and Weston, 1992).
Likewise, the use of neuron-speciﬁc monoclonal antibodies even-
tually revealed that the cohesive clusters of trunk Neural Crest-
derived cells, which we had erroneously considered to be
homogeneous populations of melanogenic cells (Loring et al.,
1981), also initially contained a subpopulation of neurogenic cells
(Vogel and Weston, 1988). Interestingly, these neurogenic cells
were progressively lost when Neural Crest cell clusters were
prevented from undergoing timely dispersal on culture substrata
in vitro. This loss in closely associated cell populations seems
paradoxical since, after dispersing in embryonic interstitial spaces,
such neurogenic cells ultimately coalesce to form ganglia in which
closely associated neuronal and glial cells differentiate. This para-
dox was resolved in a series of carefully controlled experiments
showing that prolonged cell proximity within nascent Neural Crest
cell populations led to apoptosis of neurogenic precursors
(Maynard et al., 2000). These cell interactions, probably mediated
through a Notch-Delta signaling pathway, result in selective cell
death of neurogenic precursors. The work also showed that
neurogenic cells in cultured crest cell populations that had
dispersed immediately were not susceptible to contact-mediated
death even if close cell interactions were subsequently promoted.
Such a mechanism of contact-mediated cell death suggests the
intriguing idea that prolonged contact among Neural Crest-
derived cells in the MSA could serve to selectively eliminate
neurogenic precursors that failed to undergo timely dispersal on
an appropriate interstitial migration pathway.
Second, although the time when fate restrictions occur within
Neural Crest-derived cell populations is still being debated [see
McKinney et al. (2013)], it is still clear that the cell population in
the MSA consists of a mixture of fate-restricted and partially
restricted cell types [see Fig. 9; (Krispin et al., 2010; Nitzan et al.,
2013; Thomas and Erickson, 2008)]. We cannot, in the present
review, pursue all the ramiﬁcations of the idea that timing of dispersal
of developmentally restricted subpopulations of Neural Crest-derived
cells affects their fate. Nevertheless, it is important to recognize that
fate-restricted subpopulations do exist among crest-derived cells
residing in the MSA, and that such distinct subpopulations express
speciﬁc phenotypic traits that affect their migratory behavior. It is
also clear that fate-restricted melanogenic precursors are present in
the outgrowth population of crest-derived cells from explanted trunk
neural tubes, and that these cells express a characteristic receptor
tyrosine kinase, c-kit, in vitro (Luo et al., 2003). Likewise, we now
know that c-kit-expressing melanogenic cells are able to respond to
the appropriately localized cognate ligand in vivo, which provides
both tropic cues leading to directional migration and trophic support
for survival and proliferation of these melanogenic precursors (Harris
et al., 2008; Thomas and Erickson, 2009; Wehrle-Haller et al., 2001,
1996). Similarly, neurogenic precursors in the Neural Crest-derived
population in vitro express cell type-speciﬁc receptors, such as the
neural cell-speciﬁc receptor tyrosine kinase, trk, which would make
them responsive to appropriate growth factors localized in the
embryonic environment (Luo et al., 2003); these receptors are
required for neuronal survival in appropriate embryonic locations
(Wakamatsu et al., 1998). It seems reasonable to postulate, therefore,
that such cells remain in the MSA until they acquire appropriate
receptors for speciﬁc localized growth factors as well as whatever
lineage-speciﬁc integrins (e.g., α1β1 and perhaps αvβ3) are required
to enable the recognition of appropriate substrata for locomotion.
Progressively fate-restricted subpopulations appear within NC-
derived mesenchyme
Remarkably, the time and order of segregation of fate-restricted
Neural Crest-derived subpopulations are still poorly understood.
And, of course, this information must be established before we can
know when and where to look for appropriate regulatory mechan-
isms, or to understand how such regulatory mechanisms function.
One example of this complex issue is seen in the function of FoxD3,
which seems to regulate lineage segregation in trunk Neural Crest-
derived cell populations. Speciﬁcally, the expression of FoxD3
function reportedly favors the maintenance of neurogenic and
gliagenic precursors, whereas its down-regulation results in the
appearance and subsequent maturation of melanogenic precursors
[see, for example, Kos et al. (2001); Thomas and Erickson (2009)]..
The function of FoxD3 in the so-called cranial Neural Crest (CNC) is
not so clear. Thus, for example, the proportion of gliagenic and
skeletogenic cell populations that arise in this population is
reportedly altered by the down-regulation of FoxD3 [see Drerup
et al. (2009)]. However, as we have suggested, the CNC population
most likely contains both Neural Crest-derived and Metablast-
derived cells and, unfortunately, the literature in this ﬁeld has not
yet considered the possibility that CNC cell populations actually
have a dual origin. Consequently, it is not yet clear whether FoxD3
function regulates the fate restriction of skeletogenic and neural
precursors cells within a common Neural Crest-derived precursor
population or if there is a dual origin of mesenchymal cells and the
regulatory gene actually operates in one distinct precursor popula-
tion, which, as in the case of PDGFRα (see the Mesodermal markers
section), has non-cell autonomous consequences on the appearance
of other cell types.
We have previously discussed how limit-dilution cloning stu-
dies have suggested the presence of multipotent and
developmentally-restricted precursors within crest-derived popu-
lations. We have also emphasized, however, that such methods of
clonal analysis are fraught with technical problems that prevent
unbiased estimates of the kinds and proportions of such precursors
in the original population of Neural Crest-derived cells. However,
an important advance in the clonal analysis of Neural Crest-derived
cells has constructively addressed these problems (Henion and
Weston, 1997; Luo et al., 2003).5 This modiﬁed cloning method
allows individual Neural Crest-derived clonal progenitors to be
randomly sampled with lineage-tracing dyes in the initial out-
growth from explanted neural tubes. The method does not involve
potentially damaging initial harvesting or bulk secondary culture of
primary outgrowths, nor does it impose the unnatural conditions
encountered by isolated cells trying to survive in an alien culture
environment containing unknown and uncontrolled environmental
cues. Importantly, the developmental fates of all of the randomly
marked cells can be assessed, regardless of the size of the clones
that they produce. This approach permitted an unbiased and
statistically signiﬁcant survey of the kinds and proportions of
fate-restricted clonal progenitors that are initially present in trunk
Neural Crest-derived populations and at intervals after their
emergence from the Neural Crest epithelium. The results were
remarkably informative: Although a very small proportion (o2%)
of the initial Neural Crest cell population was identiﬁed as multi-
potent (neuron-glial; glia-melanocyte) clonal progenitors, nearly
half of the randomly sampled cells produced single-phenotype
clones. A discrete, fate-restricted neuronal precursor population,
producing small clones containing 1–4 cells, could be distinguished
before melanocyte and glial precursors were present in the
population. Moreover, the presence of fate-restricted progenitors
could be inferred with this procedure well before any overt
differentiation had occurred. These lineage analyses, along with
studies of phenotypically distinct subpopulations present in Neural
5 Paul Henion's untimely death in January, 2014, truncated his many important
and insightful contributions to the Neural Crest literature. JAW respectfully
dedicates this review to his memory.
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Crest-derived populations in vitro and in vivo, gratifyingly sub-
stantiated earlier speculations about the relative time and order of
the segregation of partially and fully fate-restricted precursors
[Fig. 22; see Weston (1991)]. The lineage analyses also provided
the incentive to continue to examine the nature and timing of
interactions among Neural Crest-derived subpopulations [e.g.,
Maynard et al. (2000); Wakamatsu et al. (2000, 1998); see also
Dyachuk et al. (2014); Espinosa-Medina et al. (2014)], which
eventually result in the spatially appropriate appearance of PNS
derivatives of the Neural Crest. More importantly, similar methods
might now be applied to map the details of lineage segregation of
the skeletal and connective tissue derivatives of the Metablast
epithelium so as to determine its unique role in the development of
cranial structures of vertebrate embryos.
Some evolutionary considerations
The conventional notion that cranial skeletal and connective
tissue derivatives originate from the Neural Crest has given rise to
provocative speculations that this remarkable embryonic cell popu-
lation was the evolutionary “invention” that led to the formation of
the head and neck in craniate vertebrates. In a burst of enthusiasm,
Hall (Hall, 1998) even suggested that the Neural Crest epithelium
could be considered as a fourth germ layer that allowed unique
features of craniates to appear in vertebrate lineages after the
evolution of the neural tube and the notochord. This suggestion
followed the much-cited publication by Gans and Northcutt (Gans
and Northcutt, 1983), who proposed that Neural Crest was the
evolutionary innovation that allowed vertebrates to develop a head.
Speciﬁcally, they provided the following arguments. First, that
following the evolution of the notochord, central nerve tube, and
axial musculature, cephalochordates became less sessile, at least
during part of their life cycle. Second, that increased axial muscu-
lature enabled better pumping by pharyngeal wall muscles, which,
in turn, enhanced gas exchange and effective feeding. Finally, that
elastic recoil of the pharynx after deformation by muscle contrac-
tion would provide a mechanism to optimize pumping. They then
heuristically suggested that a novel connective tissue arising in
craniate evolution could produce chondromucoid-containing ECM
underlying such elasticity in the pharyngeal walls. Although the
cachet of the Neural Crest was certainly enhanced by their sugges-
tion that it was the source of this novel tissue, it is compelling to
think that the same evolutionary advantages could have been
conferred in the chordate lineage by the development of the
Metablast as the source of chondrogenic matrix in pharyngeal
tissues (see Fig. 15). This is consistent with the suggestion (Jeffrey,
2007) that a distinct “Neural Crest-like” cell population is present in
Ascidians—a vertebrate sister-group—and, in turn, raises important
questions about where and how the mesectoderm originated.
We have already discussed the intriguing model posited by the
Crump Laboratory (Cox et al., 2012; Das and Crump, 2012), which
provides a plausible mechanism for an ectodermal epithelial
domain to acquire mesodermal properties through epigenetic
modiﬁcations and a localized decrease in BMP signaling (Figs. 20
and 21). We have also previously speculated that appropriately
responsive cells with mesodermal potential might have arrived in
the Metablast domain by evading the process of involution from
the Epiblast during earlier gastrulation events (Breau et al., 2008;
Hatada and Stern, 1994; Weston et al., 2004). Although well
beyond the scope of the present review, it will also be of great
interest to pursue the implications of recent work [see, for
example, Yan et al. (2005), and references therein] suggesting that
new phenotypes and new developmental potential might evolve
in neighboring epithelia as a consequence of the functional
diversiﬁcation of gene orthologues that arose by prior genome
duplication early in vertebrate evolution (Yan et al., 2005). This, in
turn, is consistent with our extrapolations to cranial epithelia of
(1) the regulatory mechanisms suggested to exist in crest-derived
cells by the Crump laboratory (see Figs. 19 and 20 above), (2) the
suggestion by Jeffrey (2007) that a distinct tissue source of
connective tissue is present in Ascidians, and (3) the recent
suggestion that novel regulatory gene function for cartilaginous
tissue in early chordates might have been acquired by tissues
associated with the central nerve cord of embryos in the ancestral
lineage of craniates (Jandzik et al., 2014; see also Hall, 1999).
Final comments
The contents of this review suggest that timing is an essential
element in understanding the regulation of Neural Crest develop-
ment. This includes the time that the lateral epithelium of the
cranial neural fold undergoes EMT relative to when Neural Crest-
derived cells emerge from dorsal neural tube epithelium; the time
that fate-restricted subpopulations appear in the Neural Crest-
derived cell population relative to their emergence from Neural
Crest epithelium; and the time that fate-restricted cells remain in
the MSA before they disperse on interstitial migration pathways.
Timing has also played an important role in determining what
assumptions underlie interpretations of experiments on Neural Crest.
To appreciate this more fully, the reader might reﬂect again on the
consequences of accepting the assumption that the tissues compris-
ing cranial and trunk Neural Crest of amniote embryos were
equivalent (Le Lievre and Le Douarin, 1975), or our early assumption
that migrating Neural Crest populations were developmentally
homogeneous [see Weston (1963, 1970)]. These implicit assumptions
were called into question only when immunological and molecular
genetic approaches revealed spatially demarcated domains within
the neural folds and phenotypically distinct subpopulations within
Neural Crest-derived populations whose cells were otherwise indis-
tinguishable in vitro and in vivo. Most unfortunately, these implicit
assumptions led us to ignore the possibility of spatial heterogeneity
within this epithelium until it was ﬁnally unequivocally demon-
strated in the zebraﬁsh embryo (Schilling and Kimmel, 1994). Until
that time, the precise epithelial domains from which developmen-
tally distinct cells emerged were neither recognized nor resolved.
Moreover, in the absence of intrinsic phenotypic markers to distin-
guish epithelial domains within the neural folds, there was no way,
nor any incentive, to validate the implicit assumption that the dorsal
ridges and the lateral epithelia of the neural folds had equivalent
developmental potential, or even to suggest that they might be
developmentally different! These assumptions inadvertently
obscured the distinction between cells that originated from the
dorsal neural epithelium of the neural tube, and cells—possibly with
different antecedents and a different developmental history—that
emerged from lateral non-neural epithelium of the neural folds.
Parenthetically, it should be noted that the authors understand
that the timing of the presentation of our ideas in this review is
probably more propitious, or at least less harmful, for our career
trajectories than was the case when Julia Platt ﬁrst dared to
suggest that mesoderm-like cell types originated from embryonic
ectoderm!
Finally, therefore, we suggest that, despite the widely accepted
generalizations about the extraordinary developmental potential
of Neural Crest-derived cells, the timing might now be right to
proceed through Haldane's (Haldane, 1963) temporal stages of
dealing with the idea that cranial skeletal mesenchyme and other
mesectodermal derivatives originate evolutionarily and develop-
mentally from a distinct epithelial domain of the embryonic neural
folds—the Metablast—rather than from the Neural Crest. We are
conﬁdent that, in the fullness of time, there will be more
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opportunities to ascertain if, indeed, the putative Metablast
epithelium—genetically regulated independently of Authentic
Neural Crest—is the source of cells with mesoderm-like skeleto-
genic ability, as well as the ability to regulate the migration and
fate of authentic cranial Neural Crest-derived cells.
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